2016年から2023年の間,コモンウェルツと世界各地の癌に関する公的,慈善的研究資金,出版物,研究ネットワーク:比較分析
Anbang Du1, Markus Brede1, Stuart A McIntosh2
1School of Electronics and Computer Science, University of Southampton, Southampton, UK.
The Lancet. Oncology
|September 4, 2025
まとめ
世界的な癌研究資金は 毎年減少しており 顕著な不平等と 高い収入を持つ国々を好む 協力パターンがあります 戦略的な投資は 公平な世界的ながん対策と 癌の負担の軽減に不可欠です
科学分野:
- 世界保健
- 癌研究資金の分析
- 国際協力ネットワーク
背景:
- 世界的な癌研究 (2016-2023) への公的,慈善的資金調達には包括的な分析が必要です.
- 資金配分と国際協力のパターンを理解することは 効果的ながん対策に不可欠です
研究 の 目的:
- 連邦を中心に,世界の癌研究資金の額,配分,協力パターンを分析する.
- 研究投資や癌治療の資金提供における不平等を特定する.
- 世界的ながん研究協力と能力構築の機会を探求する.
主な方法:
- 2016年から2023年にかけての公的・慈善的な世界的な癌研究資金のデータを総合的に検討する.
- 補助金と出版協力の地図を作成するためのネットワーク分析
- コモンウェルツ諸国,アメリカ,EUとのつながりを強調する.
主要な成果:
- 年間世界的ながん研究投資は一般的に減少し,2021年にはわずかに増加した.
- コモンウェルス諸国,特に英国,オーストラリア,カナダは,コモンウェルス,米国,EU間のコラボレーションの主要なファシリテーターとして活動しています.
- 研究投資の格差と多くのがん治療の資金不足が顕著でした.
結論:
- 研究投資の優先順位を 全世界およびコモンウェルツ国内で緊急に検討する必要がある.
- 高所得の国々は低所得国との連携と 癌研究を支援する役割を果たすことができます
- 低所得地域における研究能力を構築し,世界的な癌の負担を軽減するために,戦略的投資と共同戦略が不可欠です.
関連する概念動画
Cancer Survival Analysis
445
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
445
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
Cancer
49.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.5K
Comparing the Survival Analysis of Two or More Groups
279
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
279
Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K


